Alzheimer’s Association Launches Global Trial Testing Whether GLP-1 Drugs Plus Lifestyle Changes Reduce Dementia Risk In Older Adults

PROTECT-Cog will test a GLP-1 drug added to the US POINTER lifestyle program. Here is what it compares, who can enroll and what is undecided. PROTECT-Cog will test a GLP-1 drug added to the US POINTER lifestyle program. Here is what it compares, who can enroll and what is undecided.Read More